Telehealth providers in Kentucky
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
Telehealth prescribing is allowed in Kentucky. What Kentucky requires of telehealth prescribers and pharmacies, plus listings with their verification status.
Kentucky at a glance
- Pharmacy regulator
- Kentucky Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Telehealth providers serving Kentucky
Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.
Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Kentucky (not yet confirmed)
- Prescription only, no research-use-only sales
- Public cancellation and refund policy
We may earn a commission from these links.
Telehealth prescribing rules in Kentucky
Kentucky defines telehealth in KRS 211.332(5) to include synchronous and asynchronous technology, remote patient monitoring, and audio-only encounters, and excludes care delivered by electronic mail, text, chat, or fax unless a state agency allows it; 900 KAR 12:005, Section 2(7) lists asynchronous store-and-forward technology and secure clinical text chat among the modalities providers may use. KRS 211.336 bars state agencies from requiring a provider to be physically present with the patient unless the provider decides that is medically necessary. KRS 311.5975 requires physicians using telehealth to obtain informed consent and protect confidentiality. KRS 311.597(1)(e) makes it unprofessional conduct to prescribe in response to an electronic communication without verifying the patient's identity, establishing a documented diagnosis, and keeping a current medical record, and says an electronic, on-line, or telephonic evaluation by questionnaire is inadequate for the initial evaluation or any follow-up. The Board of Medical Licensure's opinion on telemedicine (amended September 15, 2022; guidance without the force of law) says a physician-patient relationship may be established using telemedicine technologies if the standard of care is met and that prescribing based solely on static online questionnaires is not acceptable. Physicians must hold a Kentucky license (Kentucky participates in the Interstate Medical Licensure Compact). This record leaves asynchronous prescribing unknown because the law is ambiguous: asynchronous technology is recognized as telehealth and no real-time visit is required by name, but no provision says an asynchronous evaluation is enough for a first prescription, and the statute rules out an on-line evaluation by questionnaire. [2] [5] [6] [7] [8] [9] [10] [16]
Compounded GLP-1 access in Kentucky
The Kentucky Board of Pharmacy's 2025 guidance, "Important Update: Compounding Semaglutide and Tirzepatide," states that in general compounding pharmacies may not compound semaglutide or tirzepatide because they are commercially available, that adding another ingredient such as B12 does not avoid the essentially-a-copy rule, that a lower price is not a valid reason, and that noncompliant compounding may lead to action by both FDA and the Board. The narrow exceptions are a documented patient-specific change that produces a significant difference for that patient, or a return of the drug to the FDA shortage list. [3] [4] [14]
Research use only sellers in Kentucky
Only Kentucky-permitted pharmacies may dispense prescription drugs to Kentucky patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling, are not dispensed by a pharmacist, and fall outside Kentucky's compounding regulation. The Kentucky Food, Drug and Cosmetic Act, KRS 217.075, separately bars any person from selling, delivering, holding for sale, or giving away a new drug unless an application for it has become effective under the federal act; its investigational exemption covers only drugs intended solely for investigational use by qualified experts and labeled for investigational use only. [1] [12] [15]
How to check a telehealth provider in Kentucky
- Confirm the prescriber is licensed or registered to treat patients located in Kentucky; the telehealth rules above explain what Kentucky requires. [2] [5] [6] [7] [8] [9] [10] [16]
- Ask which pharmacy will fill the prescription and check it in the Kentucky Board of Pharmacy license lookup. [1] [3] [4] [11] [13]
- Get the full price in writing first: consult fees, membership fees, and the medication itself.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Kentucky. [1] [12] [15]
Common questions in Kentucky
Do I need an in-person visit to get a prescription by telehealth in Kentucky?
Not necessarily. KRS 211.336 bars state agencies that write telehealth regulations from requiring a provider to be physically present with the patient unless the provider decides it is medically necessary. The Board of Medical Licensure's telemedicine opinion, which is guidance without the force of law, says a physician-patient relationship may be established using telemedicine technologies if the standard of care is met. Kentucky law does not settle whether a visit with no live contact is enough for a first prescription. KRS 311.597 says an electronic, on-line, or telephonic evaluation by questionnaire is inadequate. The prescriber must be licensed in Kentucky. [6] [8] [9] [10]
Sources
- [1]Kentucky Board of Pharmacy
- [2]Kentucky Board of Medical Licensure
- [3]Kentucky Board of Pharmacy: Important update, compounding semaglutide and tirzepatide (2025)2025
- [4]201 KAR 2:076, Compounding (Kentucky Board of Pharmacy)
- [5]KRS 211.332, Definitions for KRS 211.332 to 211.338 (telehealth) (Kentucky Legislative Research Commission)
- [6]KRS 211.336, Duties of agency promulgating administrative regulations relating to telehealth (Kentucky Legislative Research Commission)
- [7]900 KAR 12:005, Telehealth terminology and requirements
- [8]KRS 311.5975, Duty of treating physician utilizing telehealth (Kentucky Legislative Research Commission)
- [9]KRS 311.597, Acts declared to constitute dishonorable, unethical, or unprofessional conduct (Kentucky Legislative Research Commission)
- [10]Kentucky Board of Medical Licensure: Board Opinion Regarding the Use of Telemedicine Technologies in the Practice of Medicine (amended September 15, 2022)